The application of 18F-FDG PET/CT imaging for human hepatocellular carcinoma: a narrative
review - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

The pathogenesis of cancer is influenced by interactions among genes, proteins,
metabolites and other small molecules. Understanding cancer progression at the metabolic …

Background The clinical validation of the EARL harmonization program for standardised
uptake value (SUV) metrics is well documented; however, its potential for defining metabolic …

Purpose The combination of PD-1/PD-L1 inhibitors and molecular targeted agents showed
promising efficacy for unresectable hepatocellular carcinoma (uHCC). This study aimed to …

Studies involving transcriptomics have revealed multiple molecular subtypes of
hepatocellular carcinoma (HCC). Positron emission tomography/computed tomography …

The present study analyzed the ability of metabolic burden indices from 18F‑
fluorodeoxyglucose (18F‑FDG) positron emission tomography/computed tomography …

Hepatic epithelioid hemangioendothelioma (HEHE) is a low-to-intermediate-grade
malignant mesenchymal tumor. The diagnostic and prognostic values of 2-[18F] fluoro-2 …

Objective This study was designed to investigate whether pretreatment fluorine-18-
fluorodeoxyglucose (18 F-FDG) PET/computed tomography (CT) lean body mass-corrected …

目的肝细胞肝癌(HCC) 是最常见的恶性肿瘤之一, 其恶性程度较高, 患者预后较差. 众所周知,
恶性肿瘤和正常细胞之间的葡萄糖代谢方式存在显著差异, 恶性肿瘤摄取葡萄糖明显高于正常 …

Objective: To compare the diagnostic ability and time efficiency of contrast-enhanced (CE)
whole body fluorodeoxyglucose (FDG) positron emission tomography/magnetic resonance …